156 related articles for article (PubMed ID: 8419476)
1. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
Rock KL; Rothstein L; Fleischacker C; Gamble S
J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
[TBL] [Abstract][Full Text] [Related]
3. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
4. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen Z; Reznikoff G; Dranoff G; Rock KL
J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
[TBL] [Abstract][Full Text] [Related]
5. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
Grant EP; Rock KL
J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
[TBL] [Abstract][Full Text] [Related]
6. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
7. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
8. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
9. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
11. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.
Gajewski TF; Pinnas M; Wong T; Fitch FW
J Immunol; 1991 Mar; 146(6):1750-8. PubMed ID: 1826010
[TBL] [Abstract][Full Text] [Related]
12. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
13. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
Diment S
J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
15. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
16. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.
Dang LH; Michalek MT; Takei F; Benaceraff B; Rock KL
J Immunol; 1990 Jun; 144(11):4082-91. PubMed ID: 1971292
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1992 Sep; 149(6):1905-11. PubMed ID: 1517561
[TBL] [Abstract][Full Text] [Related]
18. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
Ke Y; McGraw CL; Hunter RL; Kapp JA
Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383
[TBL] [Abstract][Full Text] [Related]
19. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
Bikoff EK
J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
